Abstract:Kittipat Suwanpitak, 1 Kampanart Huanbutta, 2 Nopphon Weeranoppanant, 3 Pornsak Sriamornsak, 4, 5 Chonlada Panpipat, 1 Tanikan Sangnim 1 1 Faculty of Pharmaceutical Sciences, Burapha University, Chonburi, 20131, Thailand; 2 Department of Manufacturing Pharmacy, College of Pharmacy, Rangsit University, Pathum Thani, 12000, Thailand; 3 Department of Chemical Engineering, Faculty of Engineering, Burapha University, Chonburi, 20131, Thailand; 4 Department of Industrial Pharmacy, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, 73000, Thailand; 5 Academy of Science, the Royal Society of Thailand, Bangkok, 10300, Thailand Correspondence: Tanikan Sangnim, Faculty of Pharmaceutical Sciences, Burapha University, 169, Seansook, Muang, Chonburi, 20131, Thailand, Email Introduction: Lipid-based nanoparticles (LNPs) is increasingly recognized for their potential in drug delivery, offering protection to hydrophobic drugs from degradation. Industrial synthesis of LNPs, exemplified by Pfizer-BioNTech and Moderna mRNA vaccines, utilizes flow chemistry or microfluidics, showcasing its scalability. This study explores the utilization of a novel design reactor, the vortex tube reactor, within flow chemistry for LNPs synthesis, aiming to optimize its conditions and compare them with batch synthesis. Methods: LNPs were synthesized using the vortex tube reactor, incorporating bovine serum albumin (BSA) as a model drug in the aqueous phase, alongside 1.2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and cholesterol in the organic phase. Design of experiments (DoE), specifically Box-Behnken design, was employed to optimize parameters, including X 1 : the flow rate ratio (10– 100 mL/min), X 2 : the aqueous-to-organic volumetric ratio (1:1– 10:1), and X 3 : the number of reactor units (1– 5 units). Responses evaluated encompassed physical properties and productivity. Optimized conditions were determined by minimizing particle size (Y 1 ), polydispersity index (Y 2 ), and zeta potential (Y 3 ), while maximizing entrapment efficiency (Y 4 ), drug loading (Y 5 ), and productivity (Y 5 ). Results: Results indicated that optimal conditions were achieved at X 1 of 100 mL/min, X 2 of 5.278, and X 3 of 1 unit. LNPs synthesized under these conditions exhibited favorable physical properties and productivity, with uniformity maintained across batches. The vortex tube reactor demonstrated superiority over batch synthesis, yielding smaller particles (166.23 ± 0.98 nm), more uniform nanoparticles (PDI 0.17 ± 0.01), and higher entrapment (67.75 ± 1.55%) and loading capacities (36.39 ± 0.83%), indicative of enhanced productivity (313.4 ± 12.88 mg/min). Conclusion: This study elucidates the potential of flow chemistry, particularly utilizing the vortex tube reactor, for large-scale LNPs formulation, offering insights into parameter relationships and advancing nanoparticle synthesis for drug delivery applications. Keywords: flow chemistry, lipid-based nanoparticles, nanoparticles synthesis, biological product Graphical Nanoparticles have transformed drug delivery, spanning sizes from 1 to 1000 nm. This innovation promises enhanced drug efficacy while minimizing side effects. These nanoparticles enable precise drug delivery to target cells, controlled release, and targeted distribution through surface modification with ligands. They are currently being developed as drug delivery systems for various substances and vaccines on the market, including AmBisome, DepoCyt, Doxil, Inflexal, Myocet, Pfizer-BioNTech vaccines, and Moderna mRNA vaccines. 1,2 Nanoparticles have garnered significant attention in drug delivery due to their unique properties, such as a high surface area-to-volume ratio, the ability to traverse biological barriers, and the capacity to encapsulate both hydrophobic and hydrophilic drugs. Various types of nanoparticles, including polymeric, inorganic, and lipid-based nanoparticles, have been developed for drug delivery applications. 3 Lipid-based nanoparticles (LNPs) constitute a subclass of nanoparticles composed primarily of lipids, which have garnered significant attention in recent years. LNPs present several advantages over alternative nanoparticle systems, including high stability, biocompatibility, and the capability to target specific cells or tissues. This targeted approach enhances drug efficacy while mitigating side effects. Moreover, the customization of LNPs through surface modification with targeting ligands further refines their specificity toward desired cells or -Abstract Truncated-

Development of a concentration‐controlled sequential nanoprecipitation for making lipid nanoparticles with high drug loading

Phase Separation‐induced Nanoprecipitation for Making Polymer Nanoparticles with High Drug Loading

Stable Polymer Nanoparticles with Exceptionally High Drug Loading by Sequential Nanoprecipitation

Controlled Fabrication of Drug‐loaded Protein Nanoparticles via Flash Nanoprecipitation

Controllable Microfluidic Production of Drug-Loaded PLGA Nanoparticles Using Partially Water-Miscible Mixed Solvent Microdroplets as a Precursor

Self-assembled lipid− polymer hybrid nanoparticles: a robust drug delivery platform

Size-controlled Lipid Nanoparticle Production Using Turbulent Mixing to Enhance Oral DNA Delivery.

Lipid Nanoparticles for Drug Delivery

Scalable synthesis of lipid nanoparticles for nucleic acid drug delivery using an isometric channel-size enlarging strategy

Recent Progress of Lipid Nanoparticles-Based Lipophilic Drug Delivery: Focus on Surface Modifications

Microfluidic generation of diverse lipid nanoparticle libraries

SPIN: rapid synthesis, purification, and concentration of small drug-loaded liposomes

One‐Step Formation of Targeted Liposomes in a Versatile Microfluidic Mixing Device

Combined Helical-Blade-strengthened Co-Flow Focusing and High-Throughput Screening for the Synthesis of Highly Homogeneous Nanoliposomes

Method for preparing ultrahigh-drug-loaded nanoparticles by sequential precipitation and complexation coacervation technology

Optimization of Lipid-Based Nanoparticles Formulation Loaded with Biological Product Using A Novel Design Vortex Tube Reactor via Flow Chemistry

Controllable Fabrication of Highly Uniform Sub‐10 nm Nanoparticles from Spontaneous Confined Nanoemulsification (Small 34/2023)

High-Precision Synthesis of RNA-Loaded Lipid Nanoparticles for Biomedical Applications

Controlled Interfacial Polymer Self-Assembly Coordinates Ultrahigh Drug Loading and Zero-Order Release in Particles Prepared under Continuous Flow.

Development of Stable and Intensified Mixing Processes for the Precise and Scalable Production of Uniform Drug Delivery Nanocarriers

High Drug Capacity of Nano-Levodopa-Liposomes: Preparation, In Vitro Release and Brain-Targeted Research